α(+)Thalassemia Antagonizes the Malaria-protective Effects of Sickle-Cell Trait.

Authors:
Amaratunga C; Fairhurst RM.

Journal:
EBioMedicine

Publication Year: 2014

DOI:
10.1016/j.ebiom.2014.10.020

PMCID:
PMC4457403

PMID:
26137505

View on PubMed View on PMC View Publisher
Journal Information

Full Title: EBioMedicine

Abbreviation: EBioMedicine

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Genetics, Medical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled ana…
Conte B; Brasó-Maristany F; Hernández AR and 23 more (2024) - Transparency Score: 4/6
Accelerometer-based physical activity is associated with the gut microbiota in 8416 individuals in …
Baldanzi G; Sayols-Baixeras S; Ekblom-Bak E and 17 more (2024) - Transparency Score: 3/6
Adults with metabolically healthy overweight or obesity present more brown adipose tissue and highe…
Jurado-Fasoli L; Sanchez-Delgado G; Alcantara JMA and 6 more (2024) - Transparency Score: 3/6
Advancing dengue vaccination using a T-cell priming peptide approach.
Farias JP; Birbrair A; Amorim JH. (2024) - Transparency Score: 2/6
Characterization of a human H3N8 influenza virus.
Gu C; Fan S; Dahn R and 7 more (2024) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure The authors are supported by the Intramural Research Program of the NIAID, NIH, and have declared no conflicts of interest."

Evidence found in paper:

"The authors are supported by the Intramural Research Program of the NIAID, NIH, and have declared no conflicts of interest."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025